Expansion opportunities BIONIK has recently expanded offices in Asia and secured exclusive distribution rights with Pro-Med Technology Ltd in Hong Kong, signaling a growing regional footprint and potential partnerships to scale sales of InMotion robotics and related rehabilitation solutions.

Clinical partnerships Strategic collaborations with Duke Lifepoint Healthcare to deploy InMotion ARM robotics in inpatient rehabilitation facilities indicate a ready channel for hospital-based sales and integration into existing stroke and neuro-rehabilitation programs.

Regulatory and market readiness Recent showings and demonstrations of InMotion Robots at major medical equipment events, along with home and ARKE exoskeleton development, point to a diversified product pipeline with multiple entry points for clinics, rehab centers, and eventual consumer-facing devices.

Funding runway With current funding of around 16 million and a revenue bracket of 1 to 10 million, there is an opportunity to position BIONIK for scaled deployments in institutional settings and potential channel financing discussions to accelerate adoption.

Global account potential Small team size (2-10 employees) paired with global ambitions suggests high responsiveness and flexibility for enterprise clients; leverage this to pursue enterprise-sized contracts with hospital networks, rehabilitation centers, and regional distributors seeking innovative neurorehabilitation tech.